Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Hyperthermia × spartalizumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 16 Neoplasm Metastasis 11 Nasopharyngeal Carcinoma 9 Melanoma 9 Carcinoma, Non-Small-Cell Lung 9 Pancreatic Neoplasms 7 Locally Advanced Rectal Cancer 7 Colorectal Neoplasms 7 Rectal Neoplasms 6 Stomach Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 4 Neoplasms 4 Carcinoma, Renal Cell 4 Recurrence 3 Lymphoma, Extranodal NK-T-Cell 3 Glioblastoma 3 Esophageal Neoplasms 3 Uterine Cervical Neoplasms 2 Solid Tumor 2 Prostatic Neoplasms 2 Nasopharyngeal Neoplasms 2 Lymphoma 2 Lung Neoplasms 2 Kidney Neoplasms 2 Gastrointestinal Stromal Tumors 2 Epstein-Barr Virus Infections 2 Cholangiocarcinoma 2 Breast Neoplasms 2 Advanced Solid Tumor 2 Urinary Bladder Neoplasms 1

Interventions

Diathermy 17 Radiotherapy 10 Drug Therapy 4 Cisplatin 4 Radiation 3 Immune Checkpoint Inhibitors 3 Fluorouracil 3 Brachytherapy 3 tislelizumab 2 Surgical Procedures, Operative 2 Immunotherapy 2 Conization 2 spartalizumab 1 anlotinib 1 Solutions 1 Radiation Dose Hypofractionation 1 Patient Reported Outcome Measures 1 Paclitaxel 1 Mitomycin 1 Ifosfamide 1 Hyperthermic Intraperitoneal Chemotherapy 1 Hyperthermia, Induced 1 Hydrogen Peroxide 1 Gemcitabine 1 Folfox protocol 1 Doxorubicin 1 Docetaxel 1 Dacarbazine 1 Cytoreduction Surgical Procedures 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06022692 2023-09-05

HEAIS001

Zhejiang Hospital

Phase 1/2 Completed

Gastrointestinal

Hyperthermia, Digestive System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡